The University of Chicago Header Logo

Connection

Christopher Salerno to Heart Failure

Back to Details
This is a "connection" page, showing publications Christopher Salerno has written about Heart Failure.
Christopher Salerno
Connection Strength
5.579
Heart Failure
  1. Ventricular assist device using a thoracotomy-based implant technique: Multi-Center Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternotomy (HM3 SWIFT). J Thorac Cardiovasc Surg. 2024 Nov; 168(5):1474-1484.e12.
    View in: PubMed
    Score: 0.422
  2. Elective HeartWare HVAD to HeartMate 3 Pump Exchange: Risk Mitigation or Increasing Risk? Ann Thorac Surg. 2023 08; 116(2):438-440.
    View in: PubMed
    Score: 0.390
  3. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. Eur J Cardiothorac Surg. 2022 06 15; 62(1).
    View in: PubMed
    Score: 0.376
  4. HVAD to HeartMate 3 Left Ventricular Assist Device Exchange: Best Practices Recommendations. Ann Thorac Surg. 2022 06; 113(6):1770-1777.
    View in: PubMed
    Score: 0.370
  5. Clinical distancing of hospitalized patients with advanced heart failure and cardiac transplantation during COVID-19. J Heart Lung Transplant. 2020 07; 39(7):730.
    View in: PubMed
    Score: 0.325
  6. Opening the "Dor," Not Always an Inferior Approach. ASAIO J. 2019 07; 65(5):e50-e51.
    View in: PubMed
    Score: 0.307
  7. Impact of Center Left Ventricular Assist Device Volume on Outcomes After Implantation: An INTERMACS Analysis. JACC Heart Fail. 2017 10; 5(10):691-699.
    View in: PubMed
    Score: 0.270
  8. INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome. J Heart Lung Transplant. 2016 Apr; 35(4):440-8.
    View in: PubMed
    Score: 0.238
  9. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014 Aug; 33(8):809-15.
    View in: PubMed
    Score: 0.212
  10. Current approaches to optimize the donor heart for transplantation. J Heart Lung Transplant. 2025 Apr; 44(4):672-680.
    View in: PubMed
    Score: 0.112
  11. The Society of Thoracic Surgeons Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients. Ann Thorac Surg. 2025 01; 119(1):34-58.
    View in: PubMed
    Score: 0.111
  12. Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND Trial. JACC Heart Fail. 2024 Mar; 12(3):438-447.
    View in: PubMed
    Score: 0.105
  13. Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device. J Am Coll Cardiol. 2023 08 29; 82(9):771-781.
    View in: PubMed
    Score: 0.102
  14. Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years. Heart Fail Clin. 2024 Jan; 20(1):83-89.
    View in: PubMed
    Score: 0.101
  15. Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 07 04; 82(1):70-81.
    View in: PubMed
    Score: 0.101
  16. Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
    View in: PubMed
    Score: 0.099
  17. The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
    View in: PubMed
    Score: 0.097
  18. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022 09 27; 328(12):1233-1242.
    View in: PubMed
    Score: 0.096
  19. Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio. J Thorac Cardiovasc Surg. 2023 12; 166(6):1684-1694.e18.
    View in: PubMed
    Score: 0.093
  20. Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support. J Thorac Cardiovasc Surg. 2022 10; 164(4):1120-1137.e2.
    View in: PubMed
    Score: 0.093
  21. Outcomes in Smaller Body Size Adults After HeartMate 3 Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2022 12; 114(6):2262-2269.
    View in: PubMed
    Score: 0.093
  22. HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. J Thorac Cardiovasc Surg. 2022 06; 163(6):2120-2127.e5.
    View in: PubMed
    Score: 0.093
  23. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants. Eur J Heart Fail. 2021 08; 23(8):1392-1400.
    View in: PubMed
    Score: 0.087
  24. The use of enoxaparin as bridge to therapeutic INR after LVAD implantation. J Cardiothorac Surg. 2020 Nov 14; 15(1):329.
    View in: PubMed
    Score: 0.084
  25. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2020 06; 39(6):529-537.
    View in: PubMed
    Score: 0.081
  26. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
    View in: PubMed
    Score: 0.075
  27. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. Circulation. 2019 01 08; 139(2):155-168.
    View in: PubMed
    Score: 0.074
  28. Left Lateral Thoracotomy for Centrifugal Continuous-Flow Left Ventricular Assist Device Placement: An Analysis from the Mechanical Circulatory Support Research Network. ASAIO J. 2018 Nov/Dec; 64(6):715-720.
    View in: PubMed
    Score: 0.073
  29. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 2018 10 30; 138(18):1923-1934.
    View in: PubMed
    Score: 0.073
  30. Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device. ASAIO J. 2018 Jul/Aug; 64(4):570-572.
    View in: PubMed
    Score: 0.072
  31. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
    View in: PubMed
    Score: 0.070
  32. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 01; 37(1):7-14.
    View in: PubMed
    Score: 0.068
  33. Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support. J Card Fail. 2017 Dec; 23(12):852-858.
    View in: PubMed
    Score: 0.067
  34. Left Ventricular Assist Devices for Advanced Heart Failure. N Engl J Med. 2017 05 11; 376(19):1894-5.
    View in: PubMed
    Score: 0.066
  35. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
    View in: PubMed
    Score: 0.066
  36. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):440-450.
    View in: PubMed
    Score: 0.064
  37. Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes. J Card Fail. 2016 Dec; 22(12):981-987.
    View in: PubMed
    Score: 0.064
  38. Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device. Ann Thorac Surg. 2017 Jan; 103(1):106-112.
    View in: PubMed
    Score: 0.063
  39. The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. JACC Heart Fail. 2015 Oct; 3(10):818-28.
    View in: PubMed
    Score: 0.059
  40. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):581-9; discussion 589.
    View in: PubMed
    Score: 0.053
  41. Successful management of asystole with an isolated left ventricular assist device. J Heart Lung Transplant. 2006 Apr; 25(4):490-2.
    View in: PubMed
    Score: 0.031
  42. Extrinsic outflow graft obstruction of the HeartMate 3 LVAD: A state-of-the-art review. J Heart Lung Transplant. 2024 Nov; 43(11):1873-1880.
    View in: PubMed
    Score: 0.027
  43. Impact of Patient Distance From Ventricular Assist Device-Implanting Center on Short- and Long-Term Outcomes. ASAIO J. 2018 Nov/Dec; 64(6):721-726.
    View in: PubMed
    Score: 0.018
  44. Bleeding Complication Rates Are Higher in Females after Continuous-Flow Left Ventricular Assist Device Implantation. ASAIO J. 2018 Nov/Dec; 64(6):748-753.
    View in: PubMed
    Score: 0.018
  45. A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 11; 37(11):1281-1284.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.